Ambry Genetics, a Tempus company, translates scientific research into clinically actionable test results based upon a deep understanding of the human genome and the biology behind genetic disease. It is a leader in genetic testing that aims to improve health by understanding the relationship between genetics and disease. Its unparalleled track record of discoveries over 25 years, and growing database that continues to expand in collaboration with academic, corporate, and pharmaceutical partners, means Ambry Genetics is first to market with innovative products and comprehensive analysis that enable clinicians to confidently inform patient health decisions. Hiring Fraud Alert: Ambry has received reports of employment scams in recent months that seek financial commitments, or requests personal information from job candidates. Unsuspecting job seekers have reported receiving unsolicited contacts by phone, email or text from individual(s) posing to be or represent Ambry recruiter(s). If you’ve experienced either of these scenarios, please visit this page to learn more about hiring fraud: https://consumer.ftc.gov/articles/job-scams. Or visit https://www.ambrygen.com/company/careers/recruitment-fraud-alert to learn more about our policy on recruitment fraud. You can confirm the legitimacy of a job posting by viewing our current open roles at https://ambrygen.com/careers.
Looking for a particular Ambry Genetics employee's phone or email?
The Ambry Genetics annual revenue was $253.2 million in 2026.
Michael Martinson is the CFO of Ambry Genetics.
860 people are employed at Ambry Genetics.
Ambry Genetics is based in Aliso Viejo, California.
The NAICS codes for Ambry Genetics are [51121, 51, 541, 54, 511210, 5112, 511].
The SIC codes for Ambry Genetics are [738, 87, 73].